In areas such as oral beauty nutrition, antioxidant support, sleep and recovery, women's health and well-being, metabolic support, and sports nutrition, users notice skin condition, mental state, sleep quality, recovery from fatigue, and how their bodies feel. Behind these experiences, however, often lie multiple systems involving oxidative stress, inflammatory responses, energy metabolism, neural regulation, microcirculation, barrier function, and cellular homeostasis. A mature formulation should do more than assemble concepts: it should begin with the body's condition, return to the underlying mechanisms, and use scientific tools for screening.

It is in this context that the Research Institute of Tsinghua in the Pearl River Delta and zebrafish-based formula screening demonstrate their importance for research and development.

I. The Research Institute of Tsinghua in the Pearl River Delta: A Research Platform Integrating Industry, Academia, and Research

The Research Institute of Tsinghua in the Pearl River Delta is a new type of research and development institution jointly established by Guangdong Province and Tsinghua University. It began formal operations in Guangzhou in 2015. Its role is to advance applied technology development, the commercialization of scientific achievements, incubation of high-tech companies, and investment in innovation and entrepreneurship. It supports innovation-driven development through a high-level, comprehensive, open, international organization that deeply integrates industry, academia, research, and application[1].

The institute's core value extends beyond its university research background to connecting original research, industry needs, technical validation, and the translation of research into applications. This platform capability is especially important for research and development in health, functional foods, and nutritional formulations. Nutrition and health products involve more than food processing alone: they are complex systems encompassing ingredient science, biological mechanisms, testing technologies, data analysis, regulatory boundaries, and the consumer experience.

In life science-related work, the institute also demonstrates the integration of biotechnology, big data, and artificial intelligence. For example, the Rare Disease Data Center (RDDC), jointly established by the institute and Cyagen, integrates information on diseases, genes, mutations, drug development, and animal models, and provides AI and bioinformatics tools for pathogenicity prediction, RNA splicing prediction, sequence alignment, and pathway analysis[2]. Although this platform primarily serves genetic disease and biomedical research, its underlying approach also offers lessons for nutritional product development. Future formulation work cannot rely on experience alone; it should increasingly emphasize a closed loop connecting data, models, mechanisms, and validation.

II. Why Does Formula Screening Need Biological Models?

Traditional nutritional formulation research often starts with the literature: an ingredient has antioxidant research, a plant extract has inflammation-related research, or an amino acid is associated with sleep or exercise recovery. Research findings on a single ingredient, however, do not establish that a combined formulation will necessarily be effective.

A formulation is a combination system. Ingredients may act synergistically or merely duplicate one another; their actions may align or counteract one another. Each may have supporting evidence when considered alone, yet combining them does not necessarily produce a better result. Formula development therefore needs a tool between in vitro experiments and human studies to compare approaches at an early stage and assess which combinations warrant further development.

The zebrafish model is one such tool.

Zebrafish are small vertebrate model organisms with transparent embryos, rapid development, and high reproductive output, making them suitable for live observation and high-throughput screening. Research shows similarities between zebrafish and humans across many genes and basic physiological processes: approximately 70% of human genes have corresponding homologs in zebrafish[3]. Zebrafish are consequently widely used in research on drug screening, toxicological assessment, development, inflammatory responses, oxidative stress, angiogenesis, lipid metabolism, and neurobehavior[4].

Importantly, zebrafish models can also be combined with green fluorescent protein technology to provide more intuitive visualization in living organisms. Green fluorescent protein, or GFP, is a transformative tool in modern life science. The discovery and development of GFP received the Nobel Prize in Chemistry in 2008. Its important contribution is enabling researchers to observe biological processes that were previously difficult to see in living cells, tissues, and even whole animals[9].

In zebrafish research, GFP can be used as a reporter or fluorescent labeling tool to observe changes in specific tissues, cells, or physiological processes. Because zebrafish embryos are transparent, combining GFP technology with zebrafish models allows researchers to more directly observe trends in blood vessels, inflammatory cells, the nervous system, tissue development, or other target pathways[10].

For nutritional formulations, the key value of a zebrafish model is that it can observe a formula's potential overall response in a complete living organism, rather than examining only one cellular indicator.

III. What Questions Can Zebrafish-Based Formula Screening Address?

Zebrafish-based formula screening is not human clinical research and cannot directly prove that a product will necessarily be effective in humans. It is better suited to early formulation development, where it can help research teams address several key questions.

First, assess whether the proposed direction has a basis.

For example, can a formula intended for oral beauty nutrition or antioxidant support show a protective trend in an oxidative-stress model? Can a formula intended for metabolic support show signals worth further investigation in models of lipid accumulation or glucose and lipid metabolism? The question is whether this direction merits continued development.

Second, compare different ingredient combinations.

Nutritional products often involve multiple ingredients acting together. Zebrafish models can compare groups receiving a single ingredient, a basic formula, or an enhanced formula to examine whether the combination actually offers advantages over a single component.

Third, optimize doses and ratios.

A higher dose is not always better. Excessive inclusion levels can create issues with cost, stability, taste, tolerability, or regulatory compliance. Zebrafish models can help researchers observe response trends across different dose ranges and provide a reference for adjusting ingredient ratios.

Fourth, provide early indications of safety.

Rapid development and high transparency in zebrafish embryos allow observation of indicators such as mortality, malformation rates, heart rate, movement behavior, and developmental status. These measures cannot replace a complete toxicological assessment, but they can serve as supplementary tools in early formula screening to help exclude clearly unsuitable combinations.

Zebrafish-based formula screening is therefore more like a “biological radar” in the early stages of development. It does not provide final conclusions about humans, but can help teams identify formula trends, optimize approaches, and recognize risks earlier.

IV. Vitargent and Xiaoyu Qince: Applications of Zebrafish and Fish Embryo Testing

In biological testing of consumer products, Vitargent and Xiaoyu Qince have long used fish embryo and zebrafish-related technologies to evaluate safety and efficacy-related aspects of foods, beverages, health supplements, cosmetics, and other products. Vitargent has an established technological foundation in medaka and zebrafish embryo testing, along with capabilities in consumer-product biological testing and database development. Its Guangzhou company, Xiaoyu Qince, also offers ingredient insights, formula selection, and efficacy testing services to the market[4].

Fish embryo and zebrafish models make some biological responses observable and measurable. They are therefore often used in consumer product development for ingredient screening, formula comparisons, and preliminary safety screening. Some fluorescence labelling and foundational developmental biology techniques have appeared in research associated with Nobel Prizes, but this does not mean that a particular assessment has received “Nobel Prize certification.” Model results can help form research hypotheses or compare samples; they cannot be equated with effects in humans or used to promise health functions for ordinary food products.

The boundaries of these tests also need to be understood clearly. Zebrafish and fish embryo experiments are better suited to observing early-stage trends, comparing formulations, and selecting development directions. They help research teams assess relationships between ingredient combinations, dose ratios, and model indicators earlier, providing a reference for subsequent formulation optimization.

V. From Individual Ingredients to System-Based Formulations: The Research Value of Zebrafish Screening

The body's condition is not determined by a single factor. Nutrition, stress, sleep, immunity, inflammation, metabolism, microbial ecology, and cellular energy are often interconnected and regulated together. Many outward manifestations result not from a change in one indicator, but from several systems remaining outside a stable state over time.

For example, dull skin may involve more than a lack of antioxidants; oxidative stress, glycation stress, insufficient sleep, microcirculation, inflammatory responses, and gut metabolism may also be involved. Poor sleep quality is not simply slow sleep onset, but may also relate to the stress axis, neural excitation, recovery rhythms, and cellular energy status. Slow recovery after exercise may involve energy metabolism, muscle microdamage, inflammatory regulation, and oxidative stress.

Mature formulation development should therefore move from the efficacy of a single ingredient toward support across multiple pathways. Zebrafish-based formula screening can help researchers observe changes in indicators related to different pathways within a complete living organism, advancing a formula from a combination of concepts toward mechanistic validation.

In other words, zebrafish screening is not intended to make an ingredient appear more extraordinary. It helps researchers assess more rationally whether a formulation addresses the same bodily concern, whether the ingredients act synergistically, and whether the proposed direction merits further optimization. This research method advances “scientific formulation” from ingredient rationale toward model-based validation.

VI. SUPER-SYN: Turning Screening Technology into Formulation Development Capability

For SUPER-SYN, the value of zebrafish-based formula screening lies in bringing formulation development into scientific, orderly validation, rather than merely adding a laboratory label to a product.

SUPER-SYN focuses on the mechanisms underlying users' actual conditions, rather than the popularity of an individual ingredient concept. Slow recovery after staying up late, a lack of skin radiance, fatigue after exercise, feeling unrefreshed after sleep, and changes in well-being before menstruation are not caused by a single pathway. The brand's task is to translate these consumer descriptions into mechanistic questions and then translate those questions into ingredient selection, formula structure, and validation indicators.

The industry–academia–research and biotechnology platforms represented by the Research Institute of Tsinghua in the Pearl River Delta provide a broader technological background for translating research into applications. Fish embryo and zebrafish testing represented by Vitargent and Xiaoyu Qince allow formulas to be compared and screened through models at an early stage. SUPER-SYN's role is to translate these research platforms, testing tools, and technological capabilities into product approaches that consumers can understand, use, and experience over the long term.

SUPER-SYN and Vitargent / Xiaoyu Qince have collaborated in the field of oral anti-aging nutrition and established an oral anti-aging formulation research institute, focusing on emerging ingredients, a biological big-data platform, a testing center, and pioneering formulation development[8]. The significance of this cooperation is to move testing earlier into the development process, rather than treating test results as a marketing endpoint. The approach first breaks down the body's condition, then establishes mechanistic hypotheses, screens ingredient combinations, and finally observes trends through models to continuously optimize formulas.

The capability reflected by SUPER-SYN therefore goes beyond simply having collaborative resources. It connects emerging ingredients, research platforms, zebrafish testing, and user needs into a clearer development pathway: start with the user's condition, identify underlying mechanisms, screen emerging ingredients, establish the rationale for combining them, and compare approaches through model testing. The aim is a more restrained, better-supported product message suited to long-term management of the body's condition.

This is the value of the Research Institute of Tsinghua in the Pearl River Delta and zebrafish-based formula screening: they enable development to move beyond judgment based on experience toward a scientific pathway of mechanistic hypotheses, model-based screening, formula optimization, and translation for users.

This article is educational information about nutritional science, research platforms, and formula-screening technologies only. It does not constitute disease diagnosis, treatment advice, or a promise of product efficacy. Zebrafish and fish embryo models can support early formula screening and observation of mechanistic trends, but cannot be directly equated with clinical effects in humans.

Literature and Web Sources

  1. [1] Tsinghua University News. “Inauguration Ceremony of the Research Institute of Tsinghua in the Pearl River Delta Held in Guangzhou.” 2015-12-23.
  2. [2] Rare Disease Data Center (RDDC) official website. Public materials including “Introduction to RDDC,” “AI-Empowered Genetic Disease Research: Industry Challenges and RDDC Solutions,” and “Pathway Enrichment Analysis Tool.”
  3. [3] Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498–503. DOI: 10.1038/nature12111.
  4. [4] Guangdong Society of Cosmetic Science and Technology. Public introduction to Xiaoyu Qince Technology (Guangzhou) Co., Ltd.
  5. [5] Lee H-C, Lin C-Y, Tsai H-J. Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use. Pharmaceuticals. 2021;14(6):500. DOI: 10.3390/ph14060500.
  6. [6] Lubin A, Otterstrom J, Hoade Y, et al. A versatile, automated and high-throughput drug screening platform for zebrafish embryos. Biology Open. 2021;10(9). DOI: 10.1242/bio.058513.
  7. [7] Nikam VS, Singh D, Takawale R, Ghante M. Zebrafish: An emerging whole-organism screening tool in safety pharmacology. Indian Journal of Pharmacology. 2020;52(6):505–513. DOI: 10.4103/ijp.IJP_482_19.
  8. [8] Public report. “The First ‘Formula Research Institute’ Is Established, Bringing Oral Anti-Aging into an Era of Rigorous Efficacy.” 2024.
  9. [9] NobelPrize.org. The Nobel Prize in Chemistry 2008. “for the discovery and development of the green fluorescent protein, GFP.”
  10. [10] Amsterdam A, Lin S, Hopkins N. The Aequorea victoria green fluorescent protein can be used as a reporter in live zebrafish embryos. Developmental Biology. 1995;171(1):123–129. DOI: 10.1006/dbio.1995.1265.